Home
Conditions
Lymphoma, Large B-Cell, Diffuse

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Recruiting

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT04920617

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Compassionate Cancer Care Medical Group Fountain Valley, California, United States

Boca Raton Regional Hospital Boca Raton, Florida, United States

BRCR Medical Center Inc. Hollywood, Florida, United States

BRCR Medical Center Inc. Plantation, Florida, United States

View all 50 locations

View Trial Details

Recruiting

A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome

NCT03899337

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Belfast City Hospital Belfast, United Kingdom

Royal Bournemouth Hospital Bournemouth, United Kingdom

University Hospital of Wales Cardiff, United Kingdom

Beatson West of Scotland Cancer Centre Glasgow, United Kingdom

View all 16 locations

View Trial Details

Recruiting

CD19 CAR-T Expressing IL-7 and CCL19 Combined With Anti-PD1 in RR-DLBCL

NCT05659628

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The Second Affiliated Hospital of Zhejiang University, Ningbo First Hospital Hangzhou, Zhejiang, China

Ningbo First Hospital Ningbo, Zhejiang, China

View Trial Details

Recruiting

B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

NCT05518383

Conditions: Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B-cell Lymphoma, +19 more
Locations: Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology Moscow, RF, Russia

View Trial Details

Recruiting

Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy

NCT04442412

Conditions: Diffuse Large B-cell Lymphoma, Elderly Patients, Hemic and Lymphatic Diseases, +10 more
Locations: SC Ematologia Spedali Civili Brescia, BS, Italy

UO Ematologia e CTMO di Piacenza Piacenza, PC, Italy

Ospedale Oncologico regionale CROB Rionero in Vulture, Piacenza, Italy

A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C. Ematologia Alessandria, Italy

View all 49 locations

View Trial Details

Recruiting

Impact of an APA Program on EFS in Patients With Diffuse Large-cell B Lymphoma Treated in 1st Line

NCT04670029

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: CHU Jean Minjoz Besançon, France

Clinique Victor Hugo / Centre Jean Bernard Le Mans, France

CHRU Nancy Nancy, France

Hôpital Privé du Confluent Nantes, France

View Trial Details

Recruiting

R-CDOP Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma With High Tumor Burden

NCT05040555

Conditions: Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3B, Hemic and Lymphatic Diseases, +10 more
Locations: The First Bethune Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Enrolling by Invitation

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

NCT03226704

Conditions: Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma, Hematologic Diseases, +15 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Enrolling by Invitation

A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma

NCT07348575

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

View Trial Details

Enrolling by Invitation

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

NCT07168486

Conditions: B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +31 more
Locations: University of Maryland, Baltimore Baltimore, Maryland, United States

View Trial Details

Lymphoma, Large B-Cell, Diffuse

Lymphoma, Large B-Cell, Diffuse trial results

Related conditions